Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Care Clinics|November 16, 2011
Diagnostic approach to deep venous thrombosis and pulmonary embolism in the critical care settingMarisa Magaña, Robert Bercovitch, Peter Fedullo
Annals of the American Thoracic Society|August 30, 2016
Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk FactorsMarion Delcroix, Kim Kerr, Peter Fedullo
American Journal of Respiratory and Critical Care Medicine|February 19, 2011
Chronic thromboembolic pulmonary hypertensionPeter Fedullo, Kim M Kerr, Nick H Kim, et al.
The American Journal of Emergency Medicine|January 12, 2018
Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shockChristina Le, Frank Chu, Ronald Dunlay, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2010
Defining urine output criterion for acute kidney injury in critically ill patientsEtienne Macedo, Rakesh Malhotra, Rolando Claure-Del Granado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumoniaGregory B Seymann, Lorenzo Di Francesco, Bradley Sharpe, et al.
Journal of Intensive Care|July 19, 2017
Unexpected intensive care transfer of admitted patients with severe sepsisGabriel Wardi, Arvin R Wali, Julian Villar, et al.
Circulation|January 2, 2009
Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot studyNika Skoro-Sajer, Niklas Hack, Roela Sadushi-Koliçi, et al.
The Lancet. Respiratory Medicine|September 19, 2017
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
The Lancet. Respiratory Medicine|March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
Pageof 1